Mar 9 2010
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials™, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states. Core therapeutic areas covered include cardiology and metabolic disorders, gastroenterology, infections, musculoskeletal, neurology, oncology, ophthalmology, and respiratory disorders.
In December 2009, Pharmaceutical Institute announced the acquisition of these materials from GeneEd, Inc., a company specializing in life science courseware. Financial terms of the agreement were not disclosed.
"To keep pace with changes in pipeline or commercial strategy, pharmaceutical and biotech companies must be able to rapidly gain expertise in new therapeutic areas," said Garry O'Grady, Senior Vice President and General Manager of Pharmaceutical Institute. "There is a significant need for therapeutic area training resources that deliver in-depth knowledge across a wide range of disease states. Teams that quickly obtain this knowledge will have a competitive advantage in the marketplace."
The Therapeutic Area Essentials™ suite of e-courses will add to Pharmaceutical Institute's already extensive library of training resources that includes
- Managed Markets Excellence®—a complete training solution that addresses the critical need for specialized training in the complex and constantly evolving managed markets environment for pharmaceutical and biologic products
- Understanding Pharma™—an extensive introduction to the workings of the pharmaceutical and biotech industry and an end-to-end perspective on the functional areas of a typical biopharmaceutical company
- GxP and Regulatory Series—a comprehensive view of good clinical practices and regulatory guidelines within the pharmaceutical and biotech industry
Common HIV drugs linked to reduced Alzheimer's disease risk